Biocryst Pharmaceuticals Inc.
BCRX
Market Cap$2.25B
Close$
$7.62
31% downside
Current Fair Value
31% downsideOvervalued by 31% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.25 Billion |
|---|---|
| Enterprise Value | $1.93 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.43 |
| Beta | 1.08 |
| Outstanding Shares | 208,882,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -42 |
|---|---|
| PEG | 41.96 |
| Price to Sales | 5.52 |
| Price to Book Ratio | 5.52 |
| Enterprise Value to Revenue | 3.84 |
| Enterprise Value to EBIT | -247.13 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biocryst Pharmaceuticals Inc.
CEO: Jon Stonehouse